Per Oral Endoscopic Myotomy (POEM) and Prolonged Dilatation (PRD) for Achalasia

Launched by MEDICAL UNIVERSITY OF VIENNA · Aug 7, 2015

Keywords

ClinConnect Summary

This clinical trial is studying two new treatment options, Per Oral Endoscopic Myotomy (POEM) and Prolonged Dilatation (PRD), for people suffering from achalasia, a condition that makes it hard to swallow due to problems with the muscles in the esophagus. The trial aims to see how well these treatments work over the long term, especially for patients who may not have had success with traditional treatments like laparoscopic Heller myotomy or balloon dilatation. By comparing these newer methods to conventional treatments, researchers hope to find the best approach for individuals dealing with achalasia and similar esophageal issues.

To participate in the study, you need to have a confirmed diagnosis of achalasia or related conditions. The trial is open to adults aged 65 to 74, and both men and women can join. If you qualify and choose to participate, you can expect to receive one of the four treatment options being studied, with close monitoring to assess how well it works for you over time. It’s important to note that this study is currently recruiting participants, so if you or a loved one are facing challenges with achalasia, this could be an opportunity to explore new treatment options.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Confirmed diagnosis of achalsia, hypertensive lower esophageal sphincter, nutcracker esophagus, or diffuse esophageal spasm
• Exclusion Criteria:
• • Contraindication for EGD